Giovanni Pedrazzini
Reducing gap in pre-hospital delay between women and men presenting with ST-Elevation myocardial infarction.
Foster-Witassek F, Rickli H, Roffi M, Pedrazzini G, Eberli F, Fassa A, Jeger R, Fournier S, Erne P, Radovanovic D. Reducing gap in pre-hospital delay between women and men presenting with ST-Elevation myocardial infarction. Eur J Prev Cardiol 2022
13.12.2022Reducing gap in pre-hospital delay between women and men presenting with ST-Elevation myocardial infarction.
13.12.2022Eur J Prev Cardiol 2022
Foster-Witassek Fabienne, Rickli Hans, Roffi Marco, Pedrazzini Giovanni, Eberli Franz, Fassa Amir, Jeger Raban, Fournier Stephane, Erne Paul, Radovanovic Dragana
Trends in treatment and outcomes of patients with diabetes and acute myocardial infarction: Insights from the nationwide AMIS plus registry.
Stähli B, Foster Witassek F, Roffi M, Eberli F, Rickli H, Erne P, Maggiorini M, Pedrazzini G, Radovanovic D, AMIS Plus Investigators. Trends in treatment and outcomes of patients with diabetes and acute myocardial infarction: Insights from the nationwide AMIS plus registry. Int J Cardiol 2022; 368:10-16.
20.08.2022Trends in treatment and outcomes of patients with diabetes and acute myocardial infarction: Insights from the nationwide AMIS plus registry.
20.08.2022Int J Cardiol 2022; 368:10-16
Stähli Barbara E, Foster Witassek Fabienne, Roffi Marco, Eberli Franz R, Rickli Hans, Erne Paul, Maggiorini Marco, Pedrazzini Giovanni, Radovanovic Dragana, AMIS Plus Investigators
Heavy Drinking Habits Are Associated with Worse In-Hospital Outcomes in Patients with Acute Coronary Syndrome: An Insight from the AMIS Plus Registry
Tersalvi G, Erne P, Moccetti T, Jeger R, Moccetti M, Eberli F, Roffi M, Rickli H, Radovanovic D, Biasco L, Pedrazzini G. Heavy Drinking Habits Are Associated with Worse In-Hospital Outcomes in Patients with Acute Coronary Syndrome: An Insight from the AMIS Plus Registry. Cardiology 2020; 145:757-765.
20.08.2020Heavy Drinking Habits Are Associated with Worse In-Hospital Outcomes in Patients with Acute Coronary Syndrome: An Insight from the AMIS Plus Registry
20.08.2020Cardiology 2020; 145:757-765
Tersalvi Gregorio, Erne Paul, Moccetti Tiziano, Jeger Raban, Moccetti Marco, Eberli Franz, Roffi Marco, Rickli Hans, Radovanovic Dragana, Biasco Luigi, Pedrazzini Giovanni
Temporal trends in in-hospital complications of acute coronary syndromes: Insights from the nationwide AMIS Plus registry
Stähli B, Roffi M, Eberli F, Rickli H, Erne P, Maggiorini M, Pedrazzini G, Radovanovic D, AMIS Plus Investigators. Temporal trends in in-hospital complications of acute coronary syndromes: Insights from the nationwide AMIS Plus registry. Int J Cardiol 2020; 313:16-24.
17.04.2020Temporal trends in in-hospital complications of acute coronary syndromes: Insights from the nationwide AMIS Plus registry
17.04.2020Int J Cardiol 2020; 313:16-24
Stähli Barbara E, Roffi Marco, Eberli Franz R, Rickli Hans, Erne Paul, Maggiorini Marco, Pedrazzini Giovanni, Radovanovic Dragana, AMIS Plus Investigators
Differences in presentation and clinical outcomes between left or right bundle branch block and ST segment elevation in patients with acute myocardial infarction
Meyer M, Radovanovic D, Pedrazzini G, Rickli H, Roffi M, Rosemann T, Eberli F, Kurz D. Differences in presentation and clinical outcomes between left or right bundle branch block and ST segment elevation in patients with acute myocardial infarction. Eur Heart J Acute Cardiovasc Care 2020:2048872620905101.
07.02.2020Differences in presentation and clinical outcomes between left or right bundle branch block and ST segment elevation in patients with acute myocardial infarction
07.02.2020Eur Heart J Acute Cardiovasc Care 2020:2048872620905101
Meyer Matthias R, Radovanovic Dragana, Pedrazzini Giovanni, Rickli Hans, Roffi Marco, Rosemann Thomas, Eberli Franz R, Kurz David J
Temporal trends in latecomer STEMI patients: insights from the AMIS Plus registry 1997-2017
Roberto M, Pedrazzini G, Rickli H, Erne P, Quagliana A, Halasz G, Biasco L, de Benedetti E, Radovanovic D, Moccetti M. Temporal trends in latecomer STEMI patients: insights from the AMIS Plus registry 1997-2017. Rev Esp Cardiol (Engl Ed) 2019
03.12.2019Temporal trends in latecomer STEMI patients: insights from the AMIS Plus registry 1997-2017
03.12.2019Rev Esp Cardiol (Engl Ed) 2019
Roberto Marco, Pedrazzini Giovanni, Rickli Hans, Erne Paul, Quagliana Angelo, Halasz Geza, Biasco Luigi, de Benedetti Edoardo, Radovanovic Dragana, Moccetti Marco
Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II
Jeger R, Weilenmann D, Rickli H, Hansen K, Rickenbacher P, Conen D, Müller C, Osswald S, Gilgen N, Vuilliomenet A, Pedrazzini G, Pfisterer M, Vogt D, Galatius S, Abildgaard U, Naber C, Alber H, Eberli F, Kurz D, Kaiser C. Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II. PloS one 2019; 14:e0210821.
15.01.2019Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II
15.01.2019PloS one 2019; 14:e0210821
Jeger Raban V, Weilenmann Daniel, Rickli Hans, Hansen Kim Wadt, Rickenbacher Peter, Conen David, Müller Christian, Osswald Stefan, Gilgen Nicole, Vuilliomenet André, Pedrazzini Giovanni, Pfisterer Matthias, Vogt Deborah R, Galatius Søren, Abildgaard Ulrik, Naber Christoph, Alber Hannes, Eberli Franz, Kurz David J, Kaiser Christoph
Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry
Hunziker L, Pilgrim T, Rickli H, Erne P, Urban P, Cuculi F, Pedrazzini G, Jeger R, Radovanovic D, AMIS Plus Registry Investigators are listed in alphabetic order with the names of the local principal investigators. Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry. Circ Cardiovasc Interv 2019; 12:e007293.
01.01.2019Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry
01.01.2019Circ Cardiovasc Interv 2019; 12:e007293
Hunziker Lukas, Pilgrim Thomas, Rickli Hans, Erne Paul, Urban Philip, Cuculi Florim, Pedrazzini Giovanni, Jeger Raban, Radovanovic Dragana, AMIS Plus Registry Investigators are listed in alphabetic order with the names of the local principal investigators
Impact of total ischemic time on manual thrombus aspiration benefit during primary percutaneous coronary intervention
Hugelshofer S, Windecker S, Masci P, Muller O, Degrauwe S, Erne P, Radovanovic D, Rickli H, Pedrazzini G, Pilgrim T, Eberli F, Witassek F, Roffi M, Iglesias J. Impact of total ischemic time on manual thrombus aspiration benefit during primary percutaneous coronary intervention. Am Heart J 2018; 204:34-42.
10.07.2018Impact of total ischemic time on manual thrombus aspiration benefit during primary percutaneous coronary intervention
10.07.2018Am Heart J 2018; 204:34-42
Hugelshofer Sarah, Windecker Stephan, Masci Pier Giorgio, Muller Olivier, Degrauwe Sophie, Erne Paul, Radovanovic Dragana, Rickli Hans, Pedrazzini Giovanni, Pilgrim Thomas, Eberli Franz R, Witassek Fabienne, Roffi Marco, Iglesias Juan F
New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis
Biasco L, Erne P, Moccetti T, Jeger R, Eberli F, Roffi M, Rickli H, Moccetti M, Radovanovic D, Pedrazzini G. New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis. Rev Esp Cardiol (Engl Ed) 2018
10.04.2018New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis
10.04.2018Rev Esp Cardiol (Engl Ed) 2018
Biasco Luigi, Erne Paul, Moccetti Tiziano, Jeger Raban, Eberli Franz, Roffi Marco, Rickli Hans, Moccetti Marco, Radovanovic Dragana, Pedrazzini Giovanni
Gender differences in the decrease of in-hospital mortality in patients with acute myocardial infarction during the last 20 years in Switzerland
Radovanovic D, Seifert B, Roffi M, Urban P, Rickli H, Pedrazzini G, Erne P. Gender differences in the decrease of in-hospital mortality in patients with acute myocardial infarction during the last 20 years in Switzerland. Open Heart 2017; 4:e000689.
14.11.2017Gender differences in the decrease of in-hospital mortality in patients with acute myocardial infarction during the last 20 years in Switzerland
14.11.2017Open Heart 2017; 4:e000689
Radovanovic Dragana, Seifert Burkhardt, Roffi Marco, Urban Philip, Rickli Hans, Pedrazzini Giovanni, Erne Paul
Heart failure in patients admitted for acute coronary syndromes: A report from a large national registry
Jeger R, Erne P, Nossen J, Stauffer J, Pedrazzini G, Urban P, Rickli H, Eberli F, Radovanovic D, Pfister O, AMIS-Plus Investigators. Heart failure in patients admitted for acute coronary syndromes: A report from a large national registry. Clin Cardiol 2017; 40:907-913.
09.06.2017Heart failure in patients admitted for acute coronary syndromes: A report from a large national registry
09.06.2017Clin Cardiol 2017; 40:907-913
Jeger Raban V, Erne Paul, Nossen Jörg, Stauffer Jean-Christophe, Pedrazzini Giovanni, Urban Philip, Rickli Hans, Eberli Franz R, Radovanovic Dragana, Pfister Otmar, AMIS-Plus Investigators
Management and outcome of patients with acute myocardial infarction presenting with pacemaker rhythm
Bertel N, Witassek F, Puhan M, Erne P, Rickli H, Naegeli B, Pedrazzini G, Stauffer J, Radovanovic D. Management and outcome of patients with acute myocardial infarction presenting with pacemaker rhythm. Int J Cardiol 2016; 230:604-609.
20.12.2016Management and outcome of patients with acute myocardial infarction presenting with pacemaker rhythm
20.12.2016Int J Cardiol 2016; 230:604-609
Bertel Noemi, Witassek Fabienne, Puhan Milo, Erne Paul, Rickli Hans, Naegeli Barbara, Pedrazzini Giovanni, Stauffer Jean-Christophe, Radovanovic Dragana
Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial
Vassalli G, Pedrazzini G, Pfisterer M, Kaiser C, Moccetti T, Bonetti P, Bertel O, Hornig B, Rickli H, Eberli F, Erne P, Galatius S, De Servi S, Klersy C, BASKET-PROVE Investigators. Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial. Am Heart J 2015; 173:1-7.
01.12.2015Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial
01.12.2015Am Heart J 2015; 173:1-7
Vassalli Giuseppe, Pedrazzini Giovanni, Pfisterer Matthias, Kaiser Christoph, Moccetti Tiziano, Bonetti Piero, Bertel Osmund, Hornig Burkhard, Rickli Hans, Eberli Franz, Erne Paul, Galatius Soeren, De Servi Stefano, Klersy Catherine, BASKET-PROVE Investigators
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial
Kaiser C, Vuillomenet A, Steiner M, von Felten S, Vogt D, Wadt Hansen K, Rickenbacher P, Conen D, Müller C, Buser P, Hoffmann A, Pfisterer M, Weilenmann D, Rickli H, Galatius S, Jeger R, Gilgen N, Skov Jensen J, Naber C, Alber H, Wanitschek M, Eberli F, Kurz D, Pedrazzini G, Moccetti T, BASKET-PROVE II study group. Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial. Circulation 2014; 131:74-81.
19.11.2014Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial
19.11.2014Circulation 2014; 131:74-81
Kaiser Christoph, Vuillomenet André, Steiner Martin, von Felten Stefanie, Vogt Deborah R, Wadt Hansen Kim, Rickenbacher Peter, Conen David, Müller Christian, Buser Peter, Hoffmann Andreas, Pfisterer Matthias, Weilenmann Daniel, Rickli Hans, Galatius Soeren, Jeger Raban, Gilgen Nicole, Skov Jensen Jan, Naber Christoph, Alber Hannes, Wanitschek Maria, Eberli Franz, Kurz David J, Pedrazzini Giovanni, Moccetti Tiziano, BASKET-PROVE II study group
Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations
Jeger R, Kaiser C, Galatius S, Rickli H, Pedrazzini G, Erne P, Eberli F, Bonetti P, Alber H, von Felten S, Sørensen R, Pfisterer M, BASKET and BASKET-PROVE investigators. Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations. Am Heart J 2014; 168:698-705.
30.07.2014Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations
30.07.2014Am Heart J 2014; 168:698-705
Jeger Raban V, Kaiser Christoph A, Galatius Søren, Rickli Hans, Pedrazzini Giovanni, Erne Paul, Eberli Franz, Bonetti Piero O, Alber Hannes, von Felten Stefanie, Sørensen Rikke, Pfisterer Matthias E, BASKET and BASKET-PROVE investigators
Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design
Jeger R, Gilgen N, Vuilliomenet A, Jensen J, Rickli H, Pedrazzini G, Naber C, Galatius S, Eberli F, Alber H, Pfisterer M, Kaiser C. Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design. Am Heart J 2012; 163:136-41.e1.
01.02.2012Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design
01.02.2012Am Heart J 2012; 163:136-41.e1
Jeger Raban, Gilgen Nicole, Vuilliomenet André, Jensen Jan Skov, Rickli Hans, Pedrazzini Giovanni, Naber Christoph, Galatius Søren, Eberli Franz, Alber Hannes, Pfisterer Matthias, Kaiser Christoph
Impact of a nationwide public campaign on delays and outcome in Swiss patients with acute coronary syndrome
Naegeli B, Radovanovic D, Rickli H, Erne P, Seifert B, Duvoisin N, Pedrazzini G, Urban P, Bertel O. Impact of a nationwide public campaign on delays and outcome in Swiss patients with acute coronary syndrome. Eur J Cardiovasc Prev Rehabil 2011; 18:297-304.
11.02.2011Impact of a nationwide public campaign on delays and outcome in Swiss patients with acute coronary syndrome
11.02.2011Eur J Cardiovasc Prev Rehabil 2011; 18:297-304
Naegeli Barbara, Radovanovic Dragana, Rickli Hans, Erne Paul, Seifert Burkhardt, Duvoisin Nicole, Pedrazzini Giovanni, Urban Philip, Bertel Osmund
Drug-eluting versus bare-metal stents in large coronary arteries
Kaiser C, Pfisterer M, Ricard I, Brunner-La Rocca H, De Servi S, Bonetti P, Bertel O, Hornig B, Pedrazzini G, Rickli H, Alber H, Eberli F, Erne P, Galatius S, BASKET?PROVE Study Group. Drug-eluting versus bare-metal stents in large coronary arteries. N Engl J Med 2010; 363:2310-9.
16.11.2010Drug-eluting versus bare-metal stents in large coronary arteries
16.11.2010N Engl J Med 2010; 363:2310-9
Kaiser Christoph, Pfisterer Matthias, Ricard Ingrid, Brunner-La Rocca Hans-Peter, De Servi Stefano, Bonetti Piero, Bertel Osmund, Hornig Burkhard, Pedrazzini Giovanni, Rickli Hans, Alber Hannes, Eberli Franz, Erne Paul, Galatius Soeren, BASKET?PROVE Study Group
Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design
Pfisterer M, Kaiser C, De Servi S, Rickli H, Pedrazzini G, Pachinger O, Kiowski W, Hornig B, Galatius S, Erne P, Eberli F, Brunner-La Rocca H, Bonetti P, Bertel O, BASKET-PROVE Investigators. Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design. American heart journal 2008; 155:609-14.
01.04.2008Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design
01.04.2008American heart journal 2008; 155:609-14
Pfisterer Matthias, Kaiser Christoph, De Servi Stefano, Rickli Hans, Pedrazzini Giovanni, Pachinger Otmar, Kiowski Wolfgang, Hornig Burkhard, Galatius Soeren, Erne Paul, Eberli Franz R, Brunner-La Rocca Hans Peter, Bonetti Piero O, Bertel Osmund, BASKET-PROVE Investigators